Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study

• 30 April 1997
• journal article
• clinical trial
• Published by Elsevier in Gynecologic Oncology
• Vol. 65  (1) , 94-101
• https://doi.org/10.1006/gyno.1996.4577

Abstract

Keywords

• ANTIBODY
• CC49
• INTRAPERITONEAL
• OVARIAN CANCER
• CHEMOTHERAPY
• I/II
• GROSS
• SURVIVAL
• TOLERATED